Navigation Links
British Artificial Intelligence Firm Announces Exclusive License Agreement with Janssen for Clinical Stage Drug Candidates, Facilitated by Johnson & Johnson Innovation
Date:11/8/2016

LONDON, November 8, 2016 /PRNewswire/ --

BenevolentAI, a leading British artificial intelligence ("AI") company today announced significant progress in one of its key ambitions; to improve and innovate the drug development process using AI technology and provide the best medicines to the right patients.  BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica NV ("Janssen"), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by the Johnson & Johnson Innovation Centre in London.

BenevolentAI has acquired a license to a select number of novel clinical stage drug candidates and   their extensive related portfolio of   patents.  BenevolentAI scientists leveraged the AI technology to evaluate the potential of these small molecule compounds. The results indicate that there is strong promise to develop new medicines for hard to treat diseases.  

Under the terms of the license agreement, BenevolentAI will have the sole right to develop, manufacture and commercialise these novel drug candidates in all indications and in all territories. This agreement will enable BenevolentAI to accelerate its development pipeline and use its unique artificial intelligence technology to explore and provide a rich source of clinical data. BenevolentAI intends to begin late stage Phase IIb clinical trials in mid 2017. Financial terms were not disclosed.

Jackie Hunter, Board Director of BenevolentAI and CEO of BenevolentAI Bio, commented:

"We are delighted to have acquired rights to these compounds under a license agreement from Janssen. The agreement adds further depth to our clinical and pre-clinical development pipeline and marks a very exciting time for the role of artificial intelligence to benefit scientific discovery and humanity. The compounds come with a wealth of clinical and biological data that enables BenevolentAI to have further insights into the biology of diseases. Securing these novel clinical drug candidates perfectly aligns with our strategy of developing first-in-class and best-in-class stratified medicines to help patients with high unmet needs."


'/>"/>
SOURCE BenevolentAI
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
2. Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Councils Education U.K. Alumni Award
3. Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted Marihuana For Medical Purposes License Application To Health Canada
4. Smithsonians "Bionic Man" Documentary Featuring the SynCardia Total Artificial Heart Earns British Film Award
5. News Update: After 555 Days On The SynCardia Artificial Heart, Stan Larkin Is Now At Home With His Donor Heart
6. TrueCare24 Unveils Artificial Intelligence-Driven Healthcare Platform
7. Eight of The Best Total Artificial Heart Centers Honored by SynCardia
8. Worlds Leading Artificial Heart Center, La Pitié Hospital, Paris, Celebrates 30 Years and 249 Implants of the SynCardia Total Artificial Heart
9. New York Times Posts Retro Report Documentary: The Total Artificial Heart - From 1st Implant to Worlds Most Used Artificial Heart
10. Global Artificial Tears Industry
11. Insulet Announces Development Partner for the OmniPod Artificial Pancreas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2019)... ... 2019 , ... Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced ... Every Kid Healthy™ Week, to benefit Diaper Bank of North Carolina. The company encourages ... at 3165 Sweeten Creek Road in Asheville, N.C. Diapers in sizes 4, 5, and ...
(Date:3/20/2019)... ... March 20, 2019 , ... “Some years ago, when ... biofeedback had in Canada in preparing our military athletes for the annual competitions of ... different nations. I know also that today biofeedback is used to help servicemen prepare ...
(Date:3/20/2019)... ... March 20, 2019 , ... Becker's Hospital Review is pleased ... + Pharmacy Conference, held May 2-4 at the Swissotel in Chicago. The celebrity ... NFL Sunday and NFL Legend; ,     Bobbi Brown, Makeup Artist, Author, ...
Breaking Medicine Technology:
(Date:3/20/2019)... ... March 20, 2019 , ... Nike Softball Camp ... Slupinski will be leading the camp with her staff. , Coach Slupinski takes the ... Redlands where she was the head coach for 2 seasons. Slupinski had an impressive ...
(Date:3/20/2019)... ... 2019 , ... AutismOne has announced that Dr. Andrew Wakefield, an author and ... Wakefield's presentation at the AutismOne 2019 Conference will address what herd immunity is and ... lecture will examine the consequences - real and potential - for vaccines that do ...
(Date:3/20/2019)... , ... March 20, 2019 , ... Adam Equipment, a ... stand H77 at Forum Labo Paris from 26-28 March at Paris expo Porte de ... series and the Solis series of balances. Both balance lines include models ...
(Date:3/20/2019)... ... March 20, 2019 , ... Caring.com, the nation’s most visited website ... systems for 2019. The medical alert provider was recognized as the Best Standalone ... for the list based on its demonstration of excellent customer service, transparency and affordability. ...
(Date:3/19/2019)... ... ... Adult superstar, sex educator and exclusive Wicked Pictures contract star jessica drake and ... begin production on April 17 in Los Angeles. , Media members interested in attending ... Sex” brings together jessica drake with senior sex expert Joan Price as they take ...
Breaking Medicine News(10 mins):